Cargando…
Loss of MiR-664 Expression Enhances Cutaneous Malignant Melanoma Proliferation by Upregulating PLP2
Proteolipid protein 2 (PLP2) has been shown to be upregulated in several cancers, including breast cancer, hepatocellular carcinoma, osteosarcoma, and melanoma. PLP2 specifically binds to phosphatidylinositol 3 kinase to activate the protein kinase B pathway to enhance cell proliferation, adhesion,...
Autores principales: | Ding, Zhenhua, Jian, Sun, Peng, Xuebiao, Liu, Yimin, Wang, Jianyu, Zheng, Li, Ou, Chengshan, Wang, Yinghui, Zeng, Weixia, Zhou, Meijuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616445/ https://www.ncbi.nlm.nih.gov/pubmed/26287415 http://dx.doi.org/10.1097/MD.0000000000001327 |
Ejemplares similares
-
Meta-Analysis of the Safety and Efficacy of Interferon Combined With Dacarbazine Versus Dacarbazine Alone in Cutaneous Malignant Melanoma
por: Xin, Yong, et al.
Publicado: (2016) -
Characteristics and prognosis of primary malignant melanoma of the esophagus
por: Chen, Hengchi, et al.
Publicado: (2020) -
miR-365 Promotes Cutaneous Squamous Cell Carcinoma (CSCC) through Targeting Nuclear Factor I/B (NFIB)
por: Zhou, Meijuan, et al.
Publicado: (2014) -
Construction of autophagy prognostic signature and analysis of prospective molecular mechanisms in skin cutaneous melanoma patients
por: Liao, Shian, et al.
Publicado: (2021) -
GNA11 Mutation in a Patient With Cutaneous Origin Melanoma: A Case Report
por: Patel, Sapna P., et al.
Publicado: (2016)